SLDB

Conviction 97HealthcareScan · Thu, Jun 25, 2026

Bearish harami

SLDB$8.85-4.32%

ResistanceSupportVol 14

Vol MA14 3.06M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Solid Biosciences Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.solidbio.com ↗

Price8.85

Change-4.32%

Gap-0.76%

Rel volume1.83×

Avg volume2.46M

Avg $ vol19.48M

SMA 207.41

SMA 507.40

SMA 2006.34

Price vs 50+19.54%

Price vs 200+39.49%

MA stackbullish

50/200 cross—

Supertrendup · 7.41

RSI (14)65

MACD hist0.25

MACD crossbull · 9d

Stoch %K / %D73 / 86

ADX (14)22

+DI / −DI34 / 10

RSI divergence—

MACD divergence—

ATR %+6.74%

ADR %7.38%

52w high9.25

52w low3.93

From 52w high-4.32%

Above 52w low+125.19%

New 52w highNo

SqueezeOff

Bollinger width44.01%

%B0.94

Donchian pos73.39%

Donchian high9.76

Donchian low6.34

AVWAP (52w high)9.15

vs AVWAP high-3.28%

AVWAP (52w low)6.80

vs AVWAP low+30.12%

OBV trendUp

Chaikin MF (20)0.20

Today vs 20d1.83×

Avg vol (14d)3.06M

Avg vol (20d)2.46M

Avg $ vol (20d)19.48M

Market cap871.28M

RS 3m (vs SPY)+26.22%

RS 6m (vs SPY)+47.99%

RS line new highYes

Trend template8/8

Technical rank92.3

1 week+21.07%

1 month+28.63%

3 months+22.41%

6 months+47.99%

1 year+82.29%

YTD+62.39%

P/E-7.43

P/B2.33

P/S107.64

P/FCF-5.53

EPS-1.99

Div yield—

ROE-31.33%

ROA-27.72%

Debt/Eq—

Current13.10

EV/EBITDA-3.23

Gross margin—

Net margin—

Rev growth-40.57%

EPS growth-56.72%

Price target16.75

Target upside89.27%

Analyst ratingBuy

Institutional104.99%

Ent. value574.18M

Revenue0

Net income-17.98M

Gross profit—

Free cash flow-157.44M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out98.45M

Employees121

ListedThu, Jan 25, 2018

Free float66.77M

Float %67.9%

Short interest9.6M

Days to cover9.4d

Short volume51.2%

Squeeze score74 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.52 vs −$0.40

Last surprise-30.0% miss

Setup gradeA+

Conviction97 / 100

Pattern quality—

Tech rank92.3 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Thu, Sep 30, 2021 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLDB

All disclosures →

No recent disclosed trades by Congress in SLDB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLDB · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Tan Kevin CFO & Treasurer · Restricted Stock Units · 2026-01-29	Grant	56.65K	$0	2026-01-29	2026-04-21
Howton David T Chief Operating Officer · Restricted Stock Units · 2026-01-29	Grant	79.34K	$0	2026-01-29	2026-04-21
Brooks Gabriel Chief Medical Officer · Restricted Stock Units · 2026-01-29	Grant	58.85K	$0	2026-01-29	2026-04-21
Hanrahan Jessie Chief Regulatory Officer · Restricted Stock Units · 2026-01-29	Grant	54.92K	$0	2026-01-29	2026-04-21
Cumbo Alexander President and CEO · Restricted Stock Units · 2026-01-29	Grant	169.4K	$0	2026-01-29	2026-04-21
Herzich Paul Chief Technology Officer · Restricted Stock Units · 2026-01-29	Grant	54.92K	$0	2026-01-29	2026-04-21

SEC filings

EDGAR filings in SLDB · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.